The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 2

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

From the Department of Neuroradiology (T.C.B.), National Hospital for Neurology and Neurosurgery, London, UK; Department of Nuclear Medicine (M.N., A.-M.Q.), Royal Free Hospital NHS Trust, London, UK; Department of Imaging (A.D.W.), Imperial College Healthcare NHS Trust, London, UK; Department of Clinical Neurosciences (A.H.S.), Institute of Neurology, University College London, London, UK; and Department of Nuclear Medicine (J.B.), Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.